Covax, an international organization that provides vaccines against COVID-19 to poorer countries, said on Wednesday it needed $ 5.2 billion over three months to finance serum doses for 2022.
Covax celebrated almost a year of operations and its billions dose delivery last weekend after a significant boost in November and December 2021.
“By 2022, we can help stop the cove by quickly adopting the dosage, injecting it safely and following the way we do business by reaching national priorities and coverage goals,” said Seth Berkeley, head of the Vaccine Alliance. Kovacs pillars with WHO, Unicef and CEPI.
“It will help reduce the world’s epidemic risks and uncertainties,” he said in an appeal to donors.
Covax needs $ 3.7 billion to finance a 600 million dose reserve that needs to be delivered smoothly and deal with unforeseen events such as booster doses or vaccines that are compatible with newer variants.
It is intended to help another billion poor countries avoid wastage in preparing and distributing vaccines.
Finally, $ 545 million should be used to cover expenses such as transportation, syringes or insurance.
So far, Kovacs has received $ 192 million from donors.
Seth Berkeley expects the next billion doses to be delivered within four or five months of the year taken for the first billion, with supply problems severely hampering operations.
Kovacs estimates that it will save millions of lives by 2022 and halve the financial cost of the pandemic in some countries, with 45% of the population of 92 countries benefiting from vaccine donations having access to adequate doses of the vaccine.
But 25 of these countries do not have the infrastructure for an effective vaccine campaign.
WHO boss Tedros Adhanam Ghebreasus has once again condemned vaccine inequality, saying that despite the 10 billion doses of Kovid vaccines given so far, almost half of the world’s population has not been vaccinated.
He pointed out that this inequality facilitated the emergence of variants such as the Omicron and warned that “the next one could be worse”.
“In 2022, we can end the acute phase of the epidemic or extend it. World leaders have a choice, ”he added.